BMS-986500: A novel molecular glue degrader of Cyclin E1 with first-in-class potential for treating CCNE1-amplified cancers and overcoming CDK4/6 inhibitor resistance in HR+ breast cancer (EORTC-NCI-AACR 2026) - Sep 11, 2026 - Abstract #12; Pres time: Nov 20, 2026; 03:45 PM - 03:55 PM; Location: Room 111 + 112; "Abstract will be available on the day of the presentation"
Breast Cancer • Hormone Receptor Breast Cancer • Oncology • Solid Tumor • CCNE1
|